A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy

Haematologica. 2019 Oct;104(10):e460-e464. doi: 10.3324/haematol.2018.209080. Epub 2019 Mar 7.

Chloé B Steen^{1

2}, Ellen Leich³, June H Myklebust^{2

4}, Sandra Lockmer⁵, Jillian F Wise^{2

4}, Björn E Wahlin⁵, Bjørn Østenstad⁶, Knut Liestøl^{1

7}, Eva Kimby⁵, Andreas Rosenwald³, Erlend B Smeland^{2

4}, Harald Holte^{4

6}, Ole Christian Lingjærde^{8

4

9}, Marianne Brodtkorb^{10

4

6}

¹ Department of Informatics, University of Oslo, Oslo, Norway.
² Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
³ Institute of Pathology, University of Würzburg and Comprehensive Cancer Centre Mainfranken, Germany.
⁴ KG Jebsen Centre for B-Cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
⁵ Division of Haematology, Department of Medicine at Huddinge, Karolinska Institute and University Hospital, Stockholm, Sweden.
⁶ Department of Oncology, Oslo University Hospital, Oslo, Norway.
⁷ Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway.
⁸ Department of Informatics, University of Oslo, Oslo, Norway ole@ifi.uio.no.
⁹ Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
¹⁰ Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway meide@ous-hf.no.

No abstract available

Publication types